The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene symbol SPAC25B8.09 is not ambiguous in the supplied identification context: it denotes the ORF encoding UniProt Q9UTA9 in Schizosaccharomyces pombe strain 972/ATCC 24843, annotated as “uncharacterized methyltransferase C25B8.09.” Searches using the exact ORF, accession, protein name, and domain terms found no primary publication that directly characterizes this protein. A search hit for SPAC25B8.12c was rejected because it is a different neighboring ORF.
Accordingly, the strongest defensible functional statement is:
SPAC25B8.09 encodes a computationally predicted, probably soluble SAM-associated methyltransferase-superfamily protein, but its catalytic reaction, methyl acceptor, substrate class, biological pathway, interaction partners, and subcellular localization remain unknown.
The gene symbol SPAC25B8.09 is therefore literature-limited for this specific protein. The supplied domain assignments support methyltransferase-family membership, but they do not justify assigning methylation of DNA, RNA, protein, lipid, or any particular metabolite. Current reviews emphasize that SAM-utilizing proteins perform chemically diverse reactions and that even a methyltransferase-like fold does not prove simple methyl transfer or reveal substrate specificity (lee2023sadenosylmethioninemorethan pages 1-2, lee2023sadenosylmethioninemorethan pages 6-7, lee2023sadenosylmethioninemorethan pages 2-3).
The identity used throughout this report is exactly that supplied by the requester:
No conflicting use of this exact systematic ORF name was found. Importantly, SPAC25B8.12c is not SPAC25B8.09 and evidence concerning that ORF was not transferred to Q9UTA9.
The supplied annotations—Diverse_substrate_MTase (IPR051052), Methyltransf_11 (IPR013216), SAM-dependent methyltransferase superfamily (IPR029063), and Pfam Methyltransf_11 (PF08241)—are mutually consistent with a broad methyltransferase-like family assignment. They support the hypothesis that Q9UTA9 contains a fold capable of recognizing S-adenosyl-L-methionine (SAM) or a related ligand.
They do not, however, establish a complete enzyme reaction. The generic canonical methyltransferase reaction would be:
SAM + acceptor → S-adenosyl-L-homocysteine (SAH) + methylated acceptor.
For Q9UTA9, both the acceptor and the modified atom are unknown. Possible methyl acceptors across the superfamily include carbon, nitrogen, oxygen, and sulfur centers on proteins, nucleic acids, lipids, cofactors, and small metabolites. Moreover, recent expert review shows that SAM can donate groups other than methyl and that some methyltransferase-fold proteins catalyze noncanonical transfer chemistry; structurally related enzymes can also recognize different substrates (lee2023sadenosylmethioninemorethan pages 1-2, lee2023sadenosylmethioninemorethan pages 6-7, lee2023sadenosylmethioninemorethan pages 2-3).
Thus, the supplied EC designation 2.1.1.- should be read as provisional family-level classification, not evidence that a particular reaction has been demonstrated. There is presently no reported substrate specificity, kinetic constant, catalytic residue validation, SAM/SAH-binding experiment, product identification, or enzyme assay for SPAC25B8.09.
No precise biological process or pathway can currently be assigned. In particular, available evidence does not support placing SPAC25B8.09 in:
These remain candidate categories rather than annotations. Broad methyltransferase membership is insufficient to select among them because known methyltransferases modify many biomolecule classes (pham2024developmentandvalidation pages 1-2). No exact-gene interaction, epistasis, complementation, targeted mutant phenotype, or condition-specific pathway study was found.
The localization of Q9UTA9 is unknown. No exact-gene fluorescence microscopy, endogenous tagging, biochemical fractionation, organellar proteomics, targeting-sequence validation, secretion experiment, or condition-dependent relocalization study was identified.
Consequently, it would be inappropriate to label the protein nuclear, cytosolic, mitochondrial, membrane-associated, or secreted. The domain description alone does not determine where the putative reaction occurs. Localization should be established experimentally, ideally by endogenous C-terminal and N-terminal tagging with controls showing that the tagged allele retains function.
The evidence hierarchy and outstanding questions are summarized below.
| Topic | Best current statement | Evidence type/strength | What remains unknown |
|---|---|---|---|
| Identity and organism | SPAC25B8.09 corresponds to UniProt Q9UTA9, described as uncharacterized methyltransferase C25B8.09 from Schizosaccharomyces pombe strain 972 / ATCC 24843. This identity comes from the supplied UniProt metadata. The similarly numbered SPAC25B8.12c is a different ORF and was excluded. | Supplied accession-specific UniProt metadata; strong for record identity, but not independent experimental evidence of function. | Whether expression of the predicted protein has been validated at its endogenous locus in strain 972. |
| Domains and family | The supplied metadata assigns Diverse_substrate_MTase (IPR051052), Methyltransf_11 (IPR013216 and PF08241), and SAM-dependent_MTases_sf (IPR029063), consistent with membership in a broad methyltransferase superfamily. | Computational domain annotation from the supplied UniProt metadata; moderate for family membership but weak for a precise reaction. A methyltransferase-like fold alone does not prove methyl transfer or identify the acceptor (lee2023sadenosylmethioninemorethan pages 1-2, lee2023sadenosylmethioninemorethan pages 2-3). | Domain boundaries, active-site residues, SAM or SAH binding, oligomeric state, and catalytic competence. |
| Catalytic function | The most defensible annotation is a putative SAM-associated methyltransferase-family protein. EC 2.1.1.- is incomplete and does not specify an exact reaction. | Family-level inference only; low confidence for enzymatic activity. SAM-utilizing proteins can perform chemistry other than methyl transfer, so the predicted fold is not conclusive (lee2023sadenosylmethioninemorethan pages 1-2, lee2023sadenosylmethioninemorethan pages 6-7). | Whether methyl transfer occurs; donor identity; acceptor atom; reaction products; kinetics; and catalytic residues. |
| Substrate specificity | Unknown. No evidence supports assignment to DNA, RNA, protein, lipid, metabolite, or another substrate class. | No direct evidence. SAM-dependent enzymes recognize diverse substrates and can catalyze C-, N-, O-, or S-alkylation (lee2023sadenosylmethioninemorethan pages 1-2, lee2023sadenosylmethioninemorethan pages 2-3). | Native acceptor, sequence or chemical selectivity, modification site, cellular cofactor, and physiological product. |
| Localization | Unknown. No exact-gene microscopy, fractionation, organelle-targeting, or secretion evidence was found. | No protein-specific evidence located; unresolved. | Whether the protein is cytosolic, nuclear, mitochondrial, membrane-associated, or conditionally redistributed. |
| Pathway or process | No biochemical, signaling, chromatin, RNA-processing, metabolic, or stress-response pathway can currently be assigned specifically to SPAC25B8.09. | No direct pathway evidence; unresolved. Broad methyltransferase-family membership is insufficient because methyltransferases act on many biomolecule classes (pham2024developmentandvalidation pages 1-2). | Physiological pathway, interaction partners, upstream regulation, downstream effects, and condition dependence. |
| Gene-level experiments | No exact-gene primary paper was found for SPAC25B8.09 or Q9UTA9. Retrieved fission-yeast studies provided no explicit evidence establishing its molecular function, substrate, localization, or pathway. | Negative literature-search result; a strong reason for caution, although it cannot exclude unpublished or unindexed evidence. | Targeted deletion phenotypes, complementation, endogenous tagging, proteomics, interactomics, structural studies, and biochemical assays. |
| 2023 phenomics context | A 2023 S. pombe resource assayed 3,509 non-essential deletion mutants across 131 conditions, obtained quantitative results for 3,492 mutants, and generated 2,832,384 raw data points and 103,520 phenotype measurements. These data can generate hypotheses but cannot establish this protein’s catalytic activity or substrate (rodriguezlopez2023broadfunctionalprofiling pages 1-4, rodriguezlopez2023broadfunctionalprofiling pages 4-8). | Large-scale colony-growth phenomics and machine-learning GO inference; strong as a discovery resource, but weak for assigning an individual enzyme reaction without targeted validation. | Whether the SPAC25B8.09 deletion showed a reproducible condition-specific phenotype, its correlation neighborhood, and whether any prediction survives targeted validation. |
| Practical next experiments | Priorities are endogenous fluorescent tagging and fractionation; deletion or overexpression with complementation across informative stresses; recombinant purification and SAM or SAH binding tests; broad substrate panels; comparative metabolomics or proteomics; and structure-guided mutagenesis. A generic assay detecting SAH could screen candidate acceptors (pham2024developmentandvalidation pages 1-2). | Evidence-generating strategy based on current methyltransferase methods; not evidence of the protein’s present function. | The native substrate and whether activity is weak, conditional, partner-dependent, or involves non-methyl SAM chemistry. |
Table: Evidence-graded summary separating accession-specific metadata and family-level inference from experimentally established knowledge. It highlights that no exact-gene primary characterization was found and identifies the principal experiments needed for functional annotation.
The most relevant recent development is not a direct study of Q9UTA9 but a large 2023 functional-profiling resource. Rodríguez-López and colleagues measured colony-growth fitness for deletion mutants representing 3,509 non-essential S. pombe genes across 131 nutrient, drug, and stress conditions; quantitative results were obtained for 3,492 mutants. The project produced 2,832,384 raw data points and 103,520 phenotype measurements (publication: July 2023; DOI URL: https://doi.org/10.1101/2023.04.05.535764) (rodriguezlopez2023broadfunctionalprofiling pages 1-4, rodriguezlopez2023broadfunctionalprofiling pages 4-8).
The study reported 56,594 high-scoring GO predictions, including 22,060 with high information content, and an integrated set of 1,675 novel GO predictions for 783 genes. These are valuable hypothesis-generating statistics, but colony fitness, phenotype correlation, and “guilt-by-association” predictions do not identify an enzyme’s reaction or substrate. The retrieved article text did not provide an explicit, validated SPAC25B8.09-specific assignment (rodriguezlopez2023broadfunctionalprofiling pages 1-4, rodriguezlopez2023broadfunctionalprofiling pages 4-8).
Lee et al., published in March 2023, reviewed the expanding chemistry of SAM-utilizing enzymes. SAM can participate in methyl, methylene, aminocarboxypropyl, adenosyl, amino, carboxymethyl, and aminopropyl transfer, among other roles. Their analysis is directly relevant to annotation standards: a predicted methyltransferase fold is evidence for a biochemical hypothesis, not proof of substrate or reaction (DOI URL: https://doi.org/10.1039/d2np00086e) (lee2023sadenosylmethioninemorethan pages 1-2, lee2023sadenosylmethioninemorethan pages 6-7, lee2023sadenosylmethioninemorethan pages 2-3).
A June 2024 study developed a generic methyltransferase assay based on detection of SAH, the common product of canonical SAM-dependent methyl transfer (DOI URL: https://doi.org/10.1016/j.slasd.2024.100161). This provides a practical platform for screening Q9UTA9 against candidate acceptors, although SAH production would still need orthogonal confirmation and product identification (pham2024developmentandvalidation pages 1-2).
There is no documented application specific to SPAC25B8.09/Q9UTA9 in biotechnology, medicine, diagnostics, industrial fermentation, or drug discovery. Its current practical value is as an uncharacterized target for systematic functional genomics and enzyme discovery.
Potential research applications include:
None of these proposed uses demonstrates an existing physiological role.
A conservative database-quality annotation would be:
The word “putative” is essential. Recent authoritative analysis warns that methyltransferase-like architecture alone cannot distinguish conventional methyl transfer from other SAM-dependent chemistry or identify the acceptor (lee2023sadenosylmethioninemorethan pages 1-2, lee2023sadenosylmethioninemorethan pages 6-7, lee2023sadenosylmethioninemorethan pages 2-3).
SPAC25B8.09/Q9UTA9 is correctly identified as an S. pombe strain-972 protein with computationally assigned Methyltransf_11/SAM-dependent methyltransferase-superfamily domains. Beyond that family-level inference, its primary reaction, substrate specificity, biological pathway, and cellular location are unresolved. No 2023–2024 publication—or earlier exact-gene paper retrieved in this search—provides a direct functional characterization. The most scientifically defensible conclusion is therefore not to assign a specific substrate or pathway, but to treat Q9UTA9 as a putative SAM-associated methyltransferase-family protein requiring biochemical deorphanization and cellular localization studies.
References
(lee2023sadenosylmethioninemorethan pages 1-2): Yu-Hsuan Lee, Daan Ren, Byung-sun Jeon, and Hung‐wen Liu. S-adenosylmethionine: more than just a methyl donor. Natural Product Reports, 40:1521-1549, Mar 2023. URL: https://doi.org/10.1039/d2np00086e, doi:10.1039/d2np00086e. This article has 138 citations and is from a peer-reviewed journal.
(lee2023sadenosylmethioninemorethan pages 6-7): Yu-Hsuan Lee, Daan Ren, Byung-sun Jeon, and Hung‐wen Liu. S-adenosylmethionine: more than just a methyl donor. Natural Product Reports, 40:1521-1549, Mar 2023. URL: https://doi.org/10.1039/d2np00086e, doi:10.1039/d2np00086e. This article has 138 citations and is from a peer-reviewed journal.
(lee2023sadenosylmethioninemorethan pages 2-3): Yu-Hsuan Lee, Daan Ren, Byung-sun Jeon, and Hung‐wen Liu. S-adenosylmethionine: more than just a methyl donor. Natural Product Reports, 40:1521-1549, Mar 2023. URL: https://doi.org/10.1039/d2np00086e, doi:10.1039/d2np00086e. This article has 138 citations and is from a peer-reviewed journal.
(pham2024developmentandvalidation pages 1-2): Ha Pham, Meera Kumar, Anibal Ramos Martinez, Mahbbat Ali, and Robert G. Lowery. Development and validation of a generic methyltransferase enzymatic assay based on an sah riboswitch. Jun 2024. URL: https://doi.org/10.1016/j.slasd.2024.100161, doi:10.1016/j.slasd.2024.100161. This article has 8 citations and is from a peer-reviewed journal.
(rodriguezlopez2023broadfunctionalprofiling pages 1-4): María Rodríguez-López, Nicola Bordin, Jon Lees, Harry Scholes, Shaimaa Hassan, Quentin Saintain, Stephan Kamrad, Christine Orengo, and Jürg Bähler. Broad functional profiling of fission yeast proteins using phenomics and machine learning. eLife, Jul 2023. URL: https://doi.org/10.1101/2023.04.05.535764, doi:10.1101/2023.04.05.535764. This article has 49 citations and is from a domain leading peer-reviewed journal.
(rodriguezlopez2023broadfunctionalprofiling pages 4-8): María Rodríguez-López, Nicola Bordin, Jon Lees, Harry Scholes, Shaimaa Hassan, Quentin Saintain, Stephan Kamrad, Christine Orengo, and Jürg Bähler. Broad functional profiling of fission yeast proteins using phenomics and machine learning. eLife, Jul 2023. URL: https://doi.org/10.1101/2023.04.05.535764, doi:10.1101/2023.04.05.535764. This article has 49 citations and is from a domain leading peer-reviewed journal.